Focus Stocks

Hewlett Packard (HPQ)

Hewlett Packard (HPQ)


Dell (DELL)

Dell (DELL)


Facebook (FB)

Facebook (FB)


Apple (AAPL)

Apple (AAPL)


Goldman Sachs (GS)

Goldman Sachs (GS)


Featured Stories

Fred's First Quarter 2012 EPS Increase 17%

Fred's First Quarter 2012 EPS Increase 17%


Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook

Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


McDonald's Announces Quarterly Cash Dividend

McDonald's Announces Quarterly Cash Dividend


Is KB HOME Closing in to Resistance?

Is KB HOME Closing in to Resistance?


AstraZeneca US Broadens Income Eligibility for Prescription Savings Programs

WILMINGTON, Del.-( Business Wire )-

AstraZeneca (NYSE:AZN) announced today that it broadened the income eligibility for its AZ&Me™ Prescription Savings programs to enable more people to qualify for free medicines.

The new annual household income eligibility levels are $35,000 for individuals, $48,000 for couples, $60,000 for a family of three and $70,000 for a family of four.

Those with an annual household income that falls within the new income eligibility guidelines may receive AstraZeneca medicines for free if they meet all program criteria.

"We made this change to keep pace with the increased cost of living for patients and to ensure they have access to medicines they need,” said Jennifer McGovern, Director, AZ&Me Prescription Savings Programs.

Previously, AstraZeneca provided prescription savings benefits to qualified patients with a total yearly income of $30,000 for individuals, $40,000 for couples, $50,000 for a family of three and $60,000 for a family of four.

In 2010, AstraZeneca also expanded its prescription savings program to provide assistance to those with extenuating circumstances such as those who recently lost their jobs, had their incomes reduced, experienced a change in marital status or had a change in family size. Those who submit documentation showing the change in status may qualify for the program.

AstraZeneca has offered prescription savings programs for 34 years and offers one of the industry’s most generous programs. The company will continue to make program enhancements that better serve patients and the advocates who help them.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).

AstraZenecaTony Jewell, 302-885-4594


You could minimize risk by trading in stock sectors rather than individual stocks. Find out why ETFs are the hottest investment vehicle on the planet. Try ETF Profits for FREE NOW!

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Copyright © 2011 TradersHuddle.com. All Rights Reserved.